FDA Inspection 746748 — Cooperman Barnabas Medical Center Inc.

Cooperman Barnabas Medical Center Inc. — FEI 2273912

The FDA completed an inspection of Cooperman Barnabas Medical Center Inc. on September 28, 2011 in Livingston, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 28, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Livingston, NJ (United States)

Citations

IDCFRDescription
127021 CFR 211.68(b)input/output verification
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs